- ►annals.org [PDF] GG Illei, HA Austin III, M Crane, L Collins, … - Annals of internal medicine, 2001 - Am Coll Physicians Gabor G. Illei, MD; Howard A. Austin III, MD; Marianna Crane, NP; Lee Collins,
MS; Mark F. Gourley, MD; Cheryl H. Yarboro, RN; Ellen M. Vaughan, MSN; Takashi
Kuroiwa, MD; Carol L. Danning, MD; Alfred D. Steinberg, MD; John H. ... Cited by 223 - Related articles - BL Direct - All 4 versions
- ►thelancet.com AE Traynor, J Schroeder, RM Rosa, D Cheng, J … - The Lancet, 2000 - Elsevier From 1996, we selected patients with persistent SLE despite use of
cyclophosphamide. Patients underwent dose-intense immune suppression and
autologous haemopoietic stem-cell (CD34) infusion. Peripheral blood ... Cited by 200 - Related articles - BL Direct - All 7 versions
DT Boumpas, R Furie, S Manzi, GG Illei, DJ … - Arthritis and rheumatism, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 176 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org RK Burt, S Slavin, WH Burns, AM Marmont - International Journal of Hematology, 2002 - Springer Abstract Hematopoietic stem cells (HSCs) are the earliest cells of the immune
system, giving rise to B and T lymphocytes, monocytes, tissue macrophages, and
dendritic cells. In animal models, adoptive transfer of HSCs, depending on ... Cited by 164 - Related articles - BL Direct - All 11 versions
A Fassas, A Anagnostopoulos, A Kazis, K … - Journal of clinical immunology, 2000 - Springer Based on the good results of experimental transplantation in animal models of
multiple sclerosis and of other autoimmune diseases, we have treated 24 patients
suffering from chronic progressive multiple sclerosis with high-dose ... Cited by 119 - Related articles - BL Direct - All 4 versions
M Petri, RJ Jones, RA Brodsky - Arthritis and rheumatism, 2003 - assets0.pubget.com Objective. High-dose chemotherapy followed by hematopoietic stem cell
transplantation is increasingly being studied as a treatment for severe
autoimmune disorders, such as systemic lupus erythematosus (SLE). High-dose ... Cited by 105 - Related articles - View as HTML - BL Direct - All 5 versions
PV O'donnell, L Luznik, RJ Jones, GB … - Biology of Blood and Marrow Transplantation, 2002 - static.cjp.com INTRODUCTION The combination of high-dose chemoradiotherapy and allogeneic blood
or bone marrow transplantation (BMT) can cure a variety of hematologic
malignancies but is not an option for many patients who lack an HLA-matched ... Cited by 73 - Related articles - View as HTML - BL Direct - All 6 versions
RK Burt, AE Traynor, R Ramsey-Goldman - ARTHRITIS RESEARCH AND THERAPY, 2003 - biomedcentral.com Autologous hematopoietic stem cell transplant regimens for patients with cancer
are based on dose escalation of chemotherapeutic drugs that demonstrate
effectiveness at standard dosing. Borrowing this concept from the field of ... Cited by 75 - Related articles - View as HTML - BL Direct - All 11 versions
DB Drachman, RJ Jones, RA Brodsky - Annals of neurology, 2003 - interscience.wiley.com Patients with myasthenia gravis (MG) who do not respond to conventional
immunotherapeutic agents, or cannot tolerate their side effects, are considered
refractory. Ablation of the immune system followed by bone marrow ... Cited by 71 - Related articles - BL Direct - All 5 versions
